Establishment of a monoclonal antibody (1/14/16H9) for detection of equine keratan sulfate

American Journal of Veterinary Research

Volumn 59, Issue 10, 1998, Pages 1203-1208

  Okumura, Masahiro ^a   Fujinaga, Toru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KERATAN SULFATE; MONOCLONAL ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORSE; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSES; KERATAN SULFATE; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

EID: 0032174775     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Fischer DC, Kolbe-Busch S, Stöcker G, et al. Development of enzyme immunoassays specific for keratan sulphate-and core-protein-epitopes of the large aggregating proteoglycan from human articular cartilage. Eur J Clin Chem Clin Biochem 1994;32:285-291.
2. Landoni MF, Foot R, Frean S, et al. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation. Equine Vet J 1996;28:468-475.
3. Lohmander LS, Felson DT. Defining the role of molecular markers to monilor disease, intervention, and cartilage breakdown in osteoarthritis. J Rheumatol 1997;24:782-785.
4. Thonar EJ-MA, Lenz ME, Klintworth GK, et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985;28:1367-1376.
5. Block JA, Schnitzer TJ, Anderson GBJ, et al. The effect of chemonucleolysis on serum keratan sulphate levels in humans. Arthritis Rheum 1989;32:100-104.
6. Roos H, Dahlberg L, Hoerrner LA, et al. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cart 1995;3:7-14.
7. Sweet MBE, Coelho A, Schnitzler CM, et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum 1988;31:648-652.
8. Williams JM, Downey C, Thonar EJ-MA. Increase in levels of serum keratan sulfate following cartilage proteoglycan degradation in the rabbit joint. Arthritis Rheum 1988;31:557-560.
9. Poole AR. Immunochemical markers of joint inflammation, skeletal damage and repair: where are we now? Ann Rheum Dis 1994;53:3-5.
10. Poole AR, Dieppe PA. Biological markers in rheumatoid arthritis. Semin Arthritis Rheum 1994;23:17-31.
11. Caterson B. Immunological aspects of markers of joint disease. J Rheumatol 1991;18(Suppl):19-23.
12. Heinegård D, Saxne T. Macromolecular markers in joint disease. J Rheumatol 1991;18(Suppl):27-29.
13. Thonar EJ-MA, Manicourt DM, Williams J, et al. Circulating keratan sulfate: a marker of cartilage proteoglycan catabolism in osteoarthritis. J Rheumatol 1991;18(Suppl):24-26.
14. Alwan WH, Carter SD, Bennett D, et al. Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system. Res Vet Sci 1990;49:56-60.
15. Todhunter RJ, Yeager AE, Freeman KP, et al. Keratan sulfate as a marker of articular cartilage catabolism and joint treatment in ponies. Am J Vet Res 1993;54:1007-1016.
16. Okumura M, Fujinaga T, Urakawa E, et al. Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulfate concentration in foals. Am J Vet Res 1997;58: 925-929.
17. Palmer JL, Berton AL, McClain H. Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint disease. Can J Vet Res 1995;59:205-212.
18. Todhunter RJ, Fubini SL, Freeman KP, et al. Concentrations of keratan sulfate in plasma and synovial fluid from clinically normal horses and horses with joint disease. J Am Vet Med Assoc 1997;210:369-374.
19. Heinegård D, Inerot SE, Wieslander J, et al. A method for quantitation of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease. Scand J Clin Lab Invest 1985;45:421-427.
20. Kongtawelert P, Ghosh P. A new sandwich-ELISA method for the determination of keratan sulphate peptides in biological fluids employing a monoclonal antibody and labeled avidin biotin technique. Clin Chim Acta 1990;195:17-26.
21. Caterson B, Christner JE, Banker JR. Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. J Biol Chem 1983;258:8848-8854.
22. Poole AR, Webber C, Reiner A, et al. Studies of a monoclonal antibody to skeletal keratan sulphate. Biochem J 1989;260: 849-856.
23. Galfre G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981;73:3-46.
24. Gefter ML, Margulies DH, Scharff MD. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 1977;3:231-236.
25. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage culture. Connect Tissue Res 1982;9:247-248.
26. Campion GV, McCrae F, Schnitzer TJ, et al. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-1259.
27. Kliner DJ, Gorski JP, Thonar EJ-MA. Keratan sulfate levels in sera of patients bearing cartilage tumors. Cancer 1987; 59:1931-1935.
28. Saxne T, Heinegård D. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 1992;35:385-390.
29. Saxne T, Glennas A, Kvien TK, et al. Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis. Arthritis Rheum 1993; 36:20-25.
30. Thonar EJ-MA, Pachman LM, Lenz ME, et al. Age related changes in the concentration of serum keratan sulphate in children. J Clin Chem Clin Biochem 1988;26:57-63.
31. Arican M, Carter S, Bennett D, et al. Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies. Res Vet Sci 1994;56:290-297.
32. Mehraban F, Finegan CK, Moskowitz RW. Serum keratan sulphate. Quantitative and qualitative comparisons in inflammatory versus non inflammatory arthritides. Arthritis Rheum 1991; 34:383-392.
33. Thonar EJ-MA, Glant T. Serum keratan sulphate - a marker of predisposition to polyarticular osteoarthritis. Clin Biochem 1992;25:175-180.
34. Cruz TF, Malcolm AJ, Adams ME. The effect of maturation and anterior cruciate ligament transection on the level of keratan sulfate in the serum of dogs. J Rheumatol 1989;16:1345-1350.
35. Saxne T, Heinegård D, Wollheim FA. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis 1986; 45:491-497.
36. Kongtawelert P, Francis D-J, Brooks PM, et al. Application of an enzyme-linked immunosorbent assay to quantitate the release of KS peptides into fluids of the rat subcutaneous air-pouch model and the effects of chondroprotective drugs on the release process. Rheumatol Int 1989;9:77-83.
37. Carroll GJ, Bell MC, Laing BA, et al. Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxiam. Ann Rheum Dis 1992;51:850-854.